Pharmaceuticals news FT.com

AstraZeneca hit with US class action lawsuit over China regulatory probes

Lawsuit claims UK pharma giant understated the risk of government investigations

Feb 18, 2025 - 19:30
 0
AstraZeneca hit with US class action lawsuit over China regulatory probes
Lawsuit claims UK pharma giant understated the risk of government investigations
Read More

Tags:

Previous Article

Rodial Marks 25th Anniversary With London Pop-up

Next Article

In Brief: The Belt and Road Initiative Expands

Related Posts

Robert Kennedy beats back anti-vax label in testy US Senate hearing

Robert Kennedy beats back anti-vax label in testy US Se...

Feb 9, 2025  0

The inside story of Britain’s failure to clinch £450mn AstraZeneca deal

The inside story of Britain’s failure to clinch £450mn ...

Feb 9, 2025  0

Ken Griffin’s Citadel bets £300mn against drugmaker GSK

Ken Griffin’s Citadel bets £300mn against drugmaker GSK

Feb 14, 2025  0